Innovative Immunology Biotech Windward Bio Lists on Nasdaq
Windward Bio listed on Nasdaq on November 13, 2026, pricing its IPO at $17.00 per share. The stock closed its first trading day at $28.50, up 68%, giving the clinical-stage immunology biotech a market cap of roughly $1.69 billion. Qiming Venture Partners, which invested from Series A through the IPO, authored the release and touted its 11th portfolio IPO of 2026.
Key figures
- Offering Price
- 17
- Ipo date
- 2026-11-13
- First day pop
- 68%
- First day close
- 28.5
- Market cap approx
- $1.69 billion
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.